Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Table of Contents

Issue

September 2005

Supplement

View Supplement

In This Issue

CAS Device Update

CAS Clinical Trial Update

An Interview With Gary Ansel, MD

A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

By Gary Ansel, MD

CAS Training Issues

Questions remain regarding device training and credentialing.

By Takao Ohki, MD, PhD

The Transatlantic Asymptomatic Carotid Intervention Trial

A first-of-its-kind trial looks at treating asymptomatic carotid patients.

By Barry T. Katzen, MD, for the tacit investigators*

The Asymptomatic Carotid Stenosis Trials

New data support intervention in asymptomatic patients, and a new trial of stenting versus surgery is planned.

By Endovascular Today Staff

Cover Story

Carotid Artery Occlusive Therapy

A review of the history, the current state of treatment, and the issues surrounding regulation and reimbursement.

By Rodney A. White, MD

CREST Achieves Major Milestone

An update of new data regarding asymptomatic participants.

By Jamie Roberts, BSH, CCRP; Susan Hughes, BSN; MeeLee Tom, MS; Jason Avery, MPH; Alice Sheffet, PhD; Thomas G. Brott, MD; and Robert Hobson, MD

Departments

The Benefits of Simulation Training for Fellows and Residents

Long used in aviation, simulation technology is emerging as a key component of graduate medical education programs.

By David L. Dawson, MD

Innovations

Up Front

Still Waiting for the Impact

By Takao Ohki, MD, PhD

New Technology

Absorbable Metal Stent Update

Encouraging data have led to new trial designs for this exciting potential treatment.

By Endovascular Today Staff

Pharmacology

Current and Future Thrombolytic Options for Acute PAO

A review of available plasminogen activators and a description of the novel direct-acting thrombolytic alfimeprase.

By Sean P. Lyden, MD

Rebuttal

Plaque Excision in 2005 and Beyond: Rebuttal

Rebuttal of “Issues of the Past Have Yet to Be Resolved”

By Lawrence A. Garcia, MD, and James F. McKinsey, MD

September 2005 Supplement

 View Supplement

Advertisement

Latest Issues

April 2026 cover

April 2026
March 2026 cover

March 2026
February 2026 cover

February 2026

View All Issues

right-arrow Created with Sketch.
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button